Proto Labs

Q1 2026 in 2mo Q4 2025 Q3 2025 +0.11%Q2 2025 +9.97%Q1 2025 +6.24%Q4 2024 -6.29%Q3 2024 +23.58%Q2 2024 -14.52%Q1 2024 +0.77%Q4 2023 -4.73%Q3 2023 +37.24%Q2 2023 -8.52%Q1 2023 +9.10%Q4 2022 +12.49%Q3 2022 -31.31%Q2 2022 -10.37%Q1 2022 -1.54%Q4 2021 +3.72%Q3 2021 -18.87%Q2 2021 -7.19%Q1 2021 -0.85%Q4 2020 -10.10%Q3 2020 +0.49%Q2 2020 -12.19%Q1 2020 -5.05%Q4 2019 -15.72%Q3 2019 -10.33%Q2 2019 -1.74%Q1 2019 -9.89%Q4 2018 -20.43%Q3 2018 +2.17%Q2 2018 -6.67%Q1 2018 +0.96%Q4 2017 -1.30%Q3 2017 +6.59%Q2 2017 +2.66%Q1 2017 +7.31%Q4 2016 +15.12%Q3 2016 -13.61%Q2 2016 -10.26%Q1 2016 -26.43%Q4 2015 +11.33%Q3 2015 +2.81%Q2 2015 +11.35%Q1 2015 -4.09%Q4 2014 +13.42%Q3 2014 -11.45%Q2 2014 +3.72%Q1 2014 +4.15%Q4 2010 -1.57%Q4 2013 -3.85%Q3 2013 -0.14%Q2 2013 +1.36%Q1 2013 +1.60%Q4 2012 +15.40%Q3 2011 -2.75%Q3 2012 +19.21%Q2 2011 +10.62%Q2 2012 -1.44%Q1 2011 +3.73%Q4 2011 +3.73%Q1 2012 +7.39%Q3 2010 Q2 2010 Q1 2010

Jul 28, 2020

•

Jun 30, 2020

Proto Labs Q2 2020 Earnings Report

Reported financial results for the second quarter of 2020.

Key Takeaways

Proto Labs reported a revenue of $106.6 million for Q2 2020, representing an 8.1 percent decrease compared to Q2 2019. GAAP EPS was $0.47, and non-GAAP EPS was $0.59. The company delivered over 8 million parts to support the medical industry, generating $12 million in revenue.

Revenue for the second quarter of 2020 was $106.6 million, an 8.1 percent decrease compared to Q2 2019.

Net income for the second quarter of 2020 was $12.6 million, or $0.47 per diluted share.

Non-GAAP net income was $15.9 million, or $0.59 per diluted share.

The company generated $31.0 million in cash from operations during the second quarter of 2020.